As the Wall Street Journal reported on April 30, Fidelity Investments reversed course in March and marked up a number of its tech holdings.
The mutual-fund company…released valuation estimates as of March 31 for its holdings in various funds. Fidelity wrote up the value of software firm Domo Inc. by 68% after marking ti down 29% in February. Stemcentrx Inc., the cancer-drug maker that AbbVie Inc. said this past week that it would acquire for up to $9.8 billion, was marked up 61%, back to the value Fidelity paid for the shares in August.
Other shares marked up by Fidelity in March include software companies Cloudera Inc. and Nutanix Inc., each up about 20%, as well as storage firm Dropbox Inc., up 14%. Fidelity marked up ad-technology company AppNexus Inc. and software firm MongoDB Inc. over 20%. All five of those companies’ values are still down overall since December, due to prior markdowns in January and February.
Much of this re-evaluation can be attributed to the rebound of the Nasdaq in March and is a promising sign to the Venture industry going forward.